JPRN-UMIN000051981已完成Unknown
A Randomized, Double-Blind, Comparative Trial of Stimulation Electrode Placement during Electromyography-based Neuromuscular Monitoring (Pilot Study) - A Randomized, Double-Blind, Comparative Trial of Stimulation Electrode Placement during Electromyography-based Neuromuscular Monitoring (Pilot Study)
agasaki University Hospital0 个研究点目标入组 32 人开始时间: 2023年8月29日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who already have neurological disorders (e.g., paralysis) Patients with neuromuscular diseases Patients with pacemakers or implantable cardioverter defibrillators Pregnant women Patients with fragile skin where the electromyography electrode seal is applied Patients with a history of surgery on the measuring limb Patients with a history of allergy to Rocuronium or Sugammadex Patients undergoing hemodialysis Patients undergoing robot-assisted laparoscopic surgery
研究者
相似试验
进行中（未招募）
1 期
A study to assess the durability of effect and safety of nemolizumab (CD14152) in subjects with prurigo nodularis (PN)Prurigo NodularisMedDRA version: 20.0Level: LLTClassification code 10037084Term: Prurigo nodularisSystem Organ Class: 100000004858EUCTR2021-003928-32-PLGalderma S.A.40
进行中（未招募）
1 期
A study to assess the durability of effect and safety of nemolizumab (CD14152) in subjects with prurigo nodularis (PN)Prurigo NodularisMedDRA version: 20.0Level: LLTClassification code 10037084Term: Prurigo nodularisSystem Organ Class: 100000004858EUCTR2021-003928-32-ATGalderma S.A.40
进行中（未招募）
1 期
A study to assess the durability of effect and safety of nemolizumab (CD14152) in subjects with prurigo nodularis (PN)MedDRA version: 20.0Level: LLTClassification code 10037084Term: Prurigo nodularisSystem Organ Class: 100000004858Prurigo NodularisEUCTR2021-003928-32-DEGalderma S.A.100
进行中（未招募）
1 期
A study to assess the durability of effect and safety of nemolizumab (CD14152) in subjects with prurigo nodularis (PN)MedDRA version: 20.0Level: LLTClassification code 10037084Term: Prurigo nodularisSystem Organ Class: 100000004858Prurigo NodularisEUCTR2021-003928-32-BEGalderma S.A.100
进行中（未招募）
1 期
A study to assess the durability of effect and safety of nemolizumab (CD14152) in subjects with prurigo nodularis (PN)MedDRA version: 20.0Level: LLTClassification code 10037084Term: Prurigo nodularisSystem Organ Class: 100000004858Prurigo NodularisEUCTR2021-003928-32-FRGalderma S.A.100